Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
Condition(s):Mantle Cell LymphomaLast Updated:November 12, 2021Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Mantle Cell LymphomaLast Updated:November 12, 2021Not yet recruiting
Condition(s):MCL; Mantle Cell LymphomaLast Updated:February 14, 2022Recruiting
Condition(s):Lymphoma, Mantle-CellLast Updated:June 28, 2022Recruiting
Condition(s):Lymphoma, Mantle-CellLast Updated:July 20, 2022Recruiting
Condition(s):Mantle Cell LymphomaLast Updated:March 18, 2021Recruiting
Condition(s):Recurrent Mantle Cell Lymphoma; Refractory Mantle Cell LymphomaLast Updated:February 5, 2020Recruiting
Condition(s):Mantle Cell Lymphoma; LymphomaLast Updated:December 6, 2012Withdrawn
Condition(s):Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell LymphomaLast Updated:July 11, 2022Recruiting
Condition(s):Mantle Cell LymphomaLast Updated:April 24, 2014Completed
Condition(s):Mantle Cell LymphomaLast Updated:March 18, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.